Loading…
Lobbying Spend
—
Filings
47
Firms Hired
2
Active Period
2004–2015
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015" language in - H.R.6 - 21st Century Cures Act.
Client expense: — · Firm income: $10,000
Matched citations: H.R.512
Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015" language in - H.R.6 - 21st Century Cures Act.
Client expense: — · Firm income: $10,000
Matched citations: H.R.6
Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - "DISARM Act of 2015."
Client expense: — · Firm income: $10,000
Matched citations: H.R.512
Development of policies to advance the antimicrobial research and development environment. Support of H.R.4187 - "DISARM Act of 2014."
Client expense: — · Firm income: $7,500
Matched citations: H.R.4187
Development of policies to advance the antimicrobial research and development environment. Support of H.R.4187 - "DISARM Act of 2014."
Client expense: — · Firm income: $7,500
Matched citations: H.R.4187
Development of policies to advance the antimicrobial research and development environment. Support of H.R.4187 - "DISARM Act of 2014."
Client expense: — · Firm income: $7,500
Matched citations: H.R.4187
Development of policies to advance the antimicrobial research and development environment. Support of H.R.4187 - "DISARM Act of 2014."
Client expense: — · Firm income: $7,500
Matched citations: H.R.4187
Animal Drug User Fee Amendments of 2013
2013 · fourth_quarter · Firm: MEHLMAN CONSULTING, INC.
H.R. 1407, Annual Drug User Fee Agreements of 2013. Drug Quality and Security Act (Became P.L. 113-54 on 11/27/13).
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1407
Animal Drug User Fee Amendments of 2013
2013 · fourth_quarter · Firm: MEHLMAN CONSULTING, INC.
H.R. 1407, Annual Drug User Fee Agreements of 2013. Drug Quality and Security Act (Became P.L. 113-54 on 11/27/13).
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1407
Animal Drug User Fee Amendments of 2013
2013 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
H.R. 1407, Annual Drug User Fee Agreements of 2013. H. 957, S. 959, H.R. 3204, H.R. 1919, Pharmaceutical Supply Chain Security.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1407
Safeguarding America's Pharmaceuticals Act of 2013
2013 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
H.R. 1407, Annual Drug User Fee Agreements of 2013. H. 957, S. 959, H.R. 3204, H.R. 1919, Pharmaceutical Supply Chain Security.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1919
Drug Quality and Security Act
2013 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
H.R. 1407, Annual Drug User Fee Agreements of 2013. H. 957, S. 959, H.R. 3204, H.R. 1919, Pharmaceutical Supply Chain Security.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 3204
Pharmaceutical Quality, Security, and Accountability Act
2013 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
H.R. 1407, Annual Drug User Fee Agreements of 2013. H. 957, S. 959, H.R. 3204, H.R. 1919, Pharmaceutical Supply Chain Security.
Client expense: — · Firm income: $40,000
Matched citations: S. 959
Animal Drug User Fee Amendments of 2013
2013 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
S. 957, Drug Supply chain Security Act. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. H.R. 1407, Annual Drug User Fee Agreements of 2013.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1407
Safeguarding America's Pharmaceuticals Act of 2013
2013 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
S. 957, Drug Supply chain Security Act. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. H.R. 1407, Annual Drug User Fee Agreements of 2013.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1919
Drug Supply Chain Security Act
2013 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
S. 957, Drug Supply chain Security Act. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. H.R. 1407, Annual Drug User Fee Agreements of 2013.
Client expense: — · Firm income: $50,000
Matched citations: S. 957
American Taxpayer Relief Act of 2012
2012 · fourth_quarter · Firm: MEHLMAN CONSULTING, INC.
Budget issues, including Medicare Part D rebates. Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause" and Medicare Advantage. Independent Payment Advisory Board. Support efforts to ensure appropriate access to vaccines and preventive care. Medicare and Entitlement Reform. H.R. 8, The American Taxpayer Relief Act of 2012
Client expense: — · Firm income: $50,000
Matched citations: H.R. 8
American Taxpayer Relief Act of 2012
2012 · fourth_quarter · Firm: MEHLMAN CONSULTING, INC.
Tax issues: comprehensive tax reform, deferral and transfer pricing. Implementation of Budget Control Act of 2011 (Became PL 112-25 on 8-2-11) H.R. 8, The American Taxpayer Relief Act of 2012
Client expense: — · Firm income: $50,000
Matched citations: H.R. 8
Food and Drug Administration Reform Act of 2012
2012 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
Prescription drug track and trace provisions in: H.R. 5651, The Food and Drug Administration Reform Act of 2012. S. 3187, The Food and Drug Administration Safety and Innovation Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5651
United States-Korea Free Trade Agreement Implementation Act
2011 · fourth_quarter · Firm: MEHLMAN CONSULTING, INC.
H.R. 3080, US-Korea Free Trade Agreement Implementation Act (Passed House and Senate on 10-12-11 and became PL 112-41 on 10-21-11)
Client expense: — · Firm income: $50,000
Matched citations: H.R. 3080
Temporary Payroll Tax Cut Continuation Act of 2011
2011 · fourth_quarter · Firm: MEHLMAN CONSULTING, INC.
Budget issues, including Medicare Part D rebates. Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause" and Medicare Advantage. Independent Payment Advisory Board. Support efforts to ensure appropriate access to vaccines and preventive care. Implementation of Budget Control Act of 2011 (Became PL 112-25 on August 2, 2011) H.R. 3630, Temporary Payroll Tax Cut Continuation Act of 2011 H.R. 3765, Temporary Payroll Tax Cut Continuation Act of 2011 (Became PL 112-78 on 12-23-11)
Client expense: — · Firm income: $50,000
Matched citations: H.R. 3765
Medicare and Medicaid Extenders Act of 2010
2010 · fourth_quarter · Firm: MEHLMAN CONSULTING, INC.
Health Care Reform Implementation, Medicare reform, Medicaid payment. Support efforts to ensure appropriate access to vaccines and preventive care. H.R. 4994, Medicare and Medicaid Extenders Act of 2010 (Became PL-309 on 12/15/10)
Client expense: — · Firm income: $50,000
Matched citations: H.R. 4994
Investing in American Jobs and Closing Tax Loopholes Act of 2010
2010 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
Tax issues, including deferral. H.R. 5893, Investing in American Jobs and Closing Tax Loopholes Act of 2010
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5893
American Middle Class Tax (AMT) Relief Act of 2007
2010 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
Health Care Reform. Awareness and treatment of viral hepatitis (S.Res. 531, h.Res. 466, H. Res. 1309, HR 3974) H.R. 3590, Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590).
Client expense: — · Firm income: $50,000
Matched citations: H.R. 3590
Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009
2010 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
Health Care Reform. Awareness and treatment of viral hepatitis (S.Res. 531, h.Res. 466, H. Res. 1309, HR 3974) H.R. 3590, Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590).
Client expense: — · Firm income: $50,000
Matched citations: HR 3974
Source: Senate LDA